Provention Bio, Inc. Uncategorized Contracts & Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Co-Promotion Agreement, dated October 4, 2022, between Provention Bio, Inc. and Genzyme Corporation
Provention Bio, Inc.
Pharmaceuticals
NJ
2023
Letter Agreement, dated March 12, 2023, by and between the Company and Eleanor Ramos
Provention Bio, Inc.
Pharmaceuticals
2023
Letter Agreement, dated March 12, 2023, by and between the Company and Thierry Chauche
Provention Bio, Inc.
Pharmaceuticals
2023
Letter Agreement, dated March 12, 2023, by and between the Company and Ashleigh Palmer
Provention Bio, Inc.
Pharmaceuticals
2023
Scientific Advisor Agreement, dated June 1, 2022, between Provention Bio, Inc. and Jeffrey Bluestone
Provention Bio, Inc.
Pharmaceuticals
NJ
2022
Provention Bio, Inc. 2020 Inducement Plan, as amended
Provention Bio, Inc.
Pharmaceuticals
DE
2022
Description of Registrants Securities
Provention Bio, Inc.
Pharmaceuticals
2022
Description of Registrants Securities
Provention Bio, Inc.
Pharmaceuticals
2021
Description of Registrants Securities (, Exhibit 4.4)
Provention Bio, Inc.
Pharmaceuticals
2020
Form of Right of First Refusal and Co-Sale Agreement between Provention and investors for an offering completed on April 25, 2017
Provention Bio, Inc.
Pharmaceuticals
DE
2018
Form of Lock-Up Agreement with MDB Capital Group, LLC
Provention Bio, Inc.
Pharmaceuticals
DE
2018
Engagement Agreement dated September 19, 2016, between Provention and MDB Capital Group, LLC
Provention Bio, Inc.
Pharmaceuticals
NY
2018